A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)

NCT01314664 · clinicaltrials.gov ↗
TERMINATED
Status
15
Enrollment
INDUSTRY
Sponsor class

Stopped Business decision, not safety related

Conditions

Sponsor

Endo Pharmaceuticals